Cole and Jaenisch dig into AI poisoning in pharma manufacturing, how it hides in plain sight, and who should be accountable for catching it.
News|Articles|October 2, 2022
- Pharmaceutical Technology, October 2022
- Volume 46
- Issue 10
- Pages: 44–47
Application of F Charts in Continued Process Verification of OSD Forms
Author(s)Pramote Cholayudth
This article introduces a control chart technique using F statistic for continued process verification of oral solid dosage forms.
Advertisement
Two typical tests for oral solid dosage forms are dissolution and content uniformity. In continued process verification (CPV), there must be some kind of evaluation such that the validity of the two test data within the same CPV batch is demonstrated. One such evaluation tool is control charting using F data (i.e., F chart) to demonstrate that the consistency between dissolution and CU data is under statistical control.
Peer-reviewed research
Submitted: July 25, 2022
Accepted: Aug. 19, 2022
About the author
Pramote Cholayudth, cpramote2000@yahoo.com, is the founder and manager of PM Consult. He is an industrial pharmacist with more than 40 years of experience. He is a guest speaker on process validation to industrial pharmaceutical scientists organized by Thailand’s FDA.
Article details
Pharmaceutical Technology
Volume 46, Number 10
October 2022
Pages: 44–47
Citation
When referring to this article, please cite it as P. Cholayudth, " Application of F Charts in Continued Process Verification of OSD Forms," Pharmaceutical Technology 46 (10) 44–47 (2022).
Articles in this issue
about 4 years ago
Adopting Smart Development Strategiesabout 4 years ago
Reformulating Successabout 4 years ago
Analyzing Extractables and Leachables in Single-Use Systemsabout 4 years ago
Improving Sterility Using Blow-Fill-Seal Technologyabout 4 years ago
Electrochemistry for API Synthesisabout 4 years ago
Shining a Light on Lipid Nanoparticle Characterizationabout 4 years ago
The Future of Drug Delivery for Biopharmaceuticalsabout 4 years ago
The State of Contamination Controlabout 4 years ago
Biologic Standards in the Pharmacopoeias: An Updateabout 4 years ago
Choosing the Right CDMO for CGT ProgramsAdvertisement
Related to this article
Univar Solutions scientists developed a lidocaine cream built on starch, sorbitol, coconut oil, and beeswax that matched a commercial benchmark on viscosity, assay, and hydration.
FDA final guidance defines when companion app output counts as drug labeling and when device-connected or standalone apps belong in prescribing information.
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
FDA grants ravulizumab accelerated approval in IgA nephropathy after a 43.4% proteinuria cut, signaling new IV biologic demand for drug manufacturers.
Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
Ravi Kiran Kaja, PhD, USP, explains what harmonization of extractables and leachables standards looks like in practice.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Nitrosamine Problems and Industry Solutions: PharmTech Explained
2
AAPS PharmSci 360 2026: E&L Standards Harmonization
3
Why BMS, Roche, and LGM Pharma Outsourced Key Capabilities
4
Formulation and Evaluation of a Sustainable Analgesic Cream Utilizing Renewable Bio-Based Ingredients and Green Chemistry Design Principles
5